GAPDH controls extracellular vesicle biogenesis and enhances therapeutic potential of EVs in silencing the Huntingtin gene in mice via siRNA delivery
GAPDH controls extracellular vesicle biogenesis and enhances therapeutic potential of EVs in silencing the Huntingtin gene in mice via siRNA delivery
复制标题
GAPDH 控制细胞外囊泡的生物合成,并通过 siRNA 传递增强 EV 沉默小鼠亨廷顿蛋白基因的治疗潜力
DOI:
10.1101/2020.01.09.899880
复制
发表时间:
2020
期刊:
影响因子:
--
通讯作者:
Dar G
中科院分区:
文献类型:
--
作者:
Dar G
Extracellular vesicles (EVs) are biological nanoparticles with important roles in intercellular communication and pathophysiology. Their capacity to transfer biomolecules between cells has sparked efforts to bioengineer EVs as drug delivery vehicles. However, a better understanding of EV biogenesis mechanisms and function is required to unleash their considerable therapeutic potential. Here we demonstrate a novel role for GAPDH, a glycolytic enzyme, in EV assembly and secretion, and we exploit these findings to develop a GAPDH-based methodology to load therapeutic siRNAs onto EVs for targeted drug delivery to the brain. In a series of experiments, we observe high levels of GAPDH binding to the outer surface of EVsviaa phosphatidylserine binding motif, designated as G58, and discover that the tetrameric nature of GAPDH promotes extensive EV aggregation. Studies in aDrosophilaEV biogenesis model demonstrate that GAPDH is absolutely required for normal generation of intraluminal vesicles in endosomal compartments and promotes vesicle clustering both inside and outside the cell. Fusing a GAPDH-derived G58 peptide to dsRNA-binding motifs permits highly efficient loading of RNA-based drugs such as siRNA onto the surface of EVs. Such vesicles efficiently deliver siRNA to target cellsin vitroand into the brain of a Huntington’s disease mouse model after systemic injection, resulting in silencing of the huntingtin gene in multiple anatomical regions of the brain and modulation of phenotypic features of disease. Taken together, our study demonstrates a novel role for GAPDH in EV biogenesis, and that the presence of free GAPDH binding sites on EVs can be effectively exploited to substantially enhance the therapeutic potential of EV-mediated drug delivery to the brain.
登录
查看更多内容
影响因子:
12.4
作者:
Godinho, Bruno M. D. C.;Henninger, Nils;Khvorova, Anastasia
通讯作者:
Khvorova, Anastasia
影响因子:
2.7
作者:
M. Kaneda;K. Takeuchi;K. Inoue;M. Umeda
通讯作者:
M. Umeda
影响因子:
12.4
作者:
Nakase, Ikuhiko;Hirose, Hisaaki;Futaki, Shiroh
通讯作者:
Futaki, Shiroh
影响因子:
--
作者:
R. Parton;A. Vallés;I. Dobbie;Ilan Davis
通讯作者:
Ilan Davis
影响因子:
4.8
作者:
Nakagawa, T;Hirano, Y;Horigome, T
通讯作者:
Horigome, T